Cannon Gillian

Cannon Gillian is listed in filings as Director at Xenon Pharmaceuticals Inc.. This profile follows SEC Form 4 activity through Jun 8, 2026, including sale activity. Recent filings connect the profile to Xenon Pharmaceuticals Inc. (XENE) and Corcept Therapeutics Incorporated (CORT). The current snapshot covers public activity from Jun 6, 2025 to Jun 8, 2026. Reported amounts are shown as $522.8K to $63.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.